Literature DB >> 25089257

Caffeine Use Disorder: A Review of the Evidence and Future Implications.

Merideth A Addicott1.   

Abstract

The latest edition of the Diagnostic and Statistical Manual (DSM-5) has introduced new provisions for caffeine-related disorders. Caffeine Withdrawal is now an officially recognized diagnosis, and criteria for caffeine use disorder have been proposed for additional study. caffeine use disorder is intended to be characterized by cognitive, behavioral, and physiological symptoms indicative of caffeine use despite significant caffeine-related problems, similar to other Substance Use Disorders. However, since nonproblematic caffeine use is so common and widespread, it may be difficult for some health professionals to accept that caffeine use can result in the same types of pathological behaviors caused by alcohol, cocaine, opiates, or other drugs of abuse. Yet there is evidence that some individuals are psychologically and physiologically dependent on caffeine, although the prevalence and severity of these problems is unknown. This article reviews the recent changes to the DSM, the concerns regarding these changes, and some potential impacts these changes could have on caffeine consumers.

Entities:  

Keywords:  DSM; Diagnostic and Statistical Manual; caffeine-related disorders; dependence; withdrawal

Year:  2014        PMID: 25089257      PMCID: PMC4115451          DOI: 10.1007/s40429-014-0024-9

Source DB:  PubMed          Journal:  Curr Addict Rep


  30 in total

1.  Low-dose caffeine physical dependence in humans.

Authors:  R R Griffiths; S M Evans; S J Heishman; K L Preston; C A Sannerud; B Wolf; P P Woodson
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

Review 2.  Caffeine Use Disorder: A Comprehensive Review and Research Agenda.

Authors:  Steven E Meredith; Laura M Juliano; John R Hughes; Roland R Griffiths
Journal:  J Caffeine Res       Date:  2013-09

Review 3.  Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies.

Authors:  Zhenzhen Zhang; Gang Hu; Benjamin Caballero; Lawrence Appel; Liwei Chen
Journal:  Am J Clin Nutr       Date:  2011-03-30       Impact factor: 7.045

Review 4.  The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis.

Authors:  Arthur Eumann Mesas; Luz M Leon-Muñoz; Fernando Rodriguez-Artalejo; Esther Lopez-Garcia
Journal:  Am J Clin Nutr       Date:  2011-08-31       Impact factor: 7.045

Review 5.  Caffeine-Not just a stimulant.

Authors:  Michael J Glade
Journal:  Nutrition       Date:  2010-10       Impact factor: 4.008

Review 6.  Methylxanthines and drug dependence: a focus on interactions with substances of abuse.

Authors:  Micaela Morelli; Nicola Simola
Journal:  Handb Exp Pharmacol       Date:  2011

Review 7.  Is caffeine addictive?--a review of the literature.

Authors:  Sally Satel
Journal:  Am J Drug Alcohol Abuse       Date:  2006       Impact factor: 3.829

8.  Clinical importance of caffeine dependence and abuse.

Authors:  Naoshi Ogawa; Hirofumi Ueki
Journal:  Psychiatry Clin Neurosci       Date:  2007-06       Impact factor: 5.188

Review 9.  Caffeine physical dependence: a review of human and laboratory animal studies.

Authors:  R R Griffiths; P P Woodson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 10.  Caffeine, mental health, and psychiatric disorders.

Authors:  Diogo R Lara
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

View more
  10 in total

Review 1.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

2.  Development and initial psychometric validation of the Brief-Caffeine Expectancy Questionnaire (B-CaffEQ).

Authors:  Nathan T Kearns; Heidemarie Blumenthal; Prathiba Natesan; Byron L Zamboanga; Lindsay S Ham; Renee M Cloutier
Journal:  Psychol Assess       Date:  2018-06-21

3.  Concurrent Validity of Caffeine Problems and Diagnostic Criteria for Substance Use Disorders.

Authors:  Elizabeth Harstad; Georgios Sideridis; Lon Sherritt; Lydia A Shrier; Rosemary Ziemnik; Sharon Levy
Journal:  J Caffeine Res       Date:  2016-12-01

Review 4.  Evaluating the Validity of Caffeine Use Disorder.

Authors:  Alan J Budney; Dustin C Lee; Laura M Juliano
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

5.  From Pong to Pokemon Go, catching the essence of the Internet Gaming Disorder diagnosis.

Authors:  Xavier Carbonell
Journal:  J Behav Addict       Date:  2017-03-17       Impact factor: 6.756

Review 6.  The Safety of Ingested Caffeine: A Comprehensive Review.

Authors:  Jennifer L Temple; Christophe Bernard; Steven E Lipshultz; Jason D Czachor; Joslyn A Westphal; Miriam A Mestre
Journal:  Front Psychiatry       Date:  2017-05-26       Impact factor: 4.157

Review 7.  The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.

Authors:  Jack E Henningfield; Reginald V Fant; Daniel W Wang
Journal:  Psychopharmacology (Berl)       Date:  2017-12-23       Impact factor: 4.530

Review 8.  Caffeine and Primary (Migraine) Headaches-Friend or Foe?

Authors:  Karl B Alstadhaug; Anna P Andreou
Journal:  Front Neurol       Date:  2019-12-03       Impact factor: 4.003

9.  Substitute Behaviors following Residential Substance Use Treatment in the Western Cape, South Africa.

Authors:  Deborah Louise Sinclair; Steve Sussman; Maarten De Schryver; Cedric Samyn; Sabirah Adams; Maria Florence; Shazly Savahl; Wouter Vanderplasschen
Journal:  Int J Environ Res Public Health       Date:  2021-12-05       Impact factor: 3.390

10.  Validation of the Turkish Version of the Caffeine Use Disorder Questionnaire in an Adult Population.

Authors:  Seda Kaya; Mahmut Bodur; Merve İlhan Esgin; Funda Pınar Çakıroğlu; Ayşe Özfer Özçelik
Journal:  Int J Ment Health Addict       Date:  2021-11-01       Impact factor: 3.836

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.